RayzeBio is focused on improving outcomes for people with cancer by harnessing the power of targeted radioisotopes. Founded by Deborah Charych in 2018, RayzeBio is backed by investors that include Samsara BioCapital, Versant Ventures, and venBio Partners and is headquartered in San Diego.